CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 270 | +3.8% | 0.00% | – |
| Q3 2018 | $0 | – | 260 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 260 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 260 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 260 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 260 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 260 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 260 | +205.9% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 85 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 85 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |